Cellular adaptive immune system plays a crucial role in trastuzumab clinical efficacy.
Bellati
Filippo
F
Napoletano
Chiara
C
Ruscito
Ilary
I
Liberati
Marco
M
Panici
Pierluigi Benedetti
PB
Nuti
Marianna
M
D056704:Adaptive Immunity; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab; C508053:ERBB2 protein, human